For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Sequelae of Lassa Fever: Postviral Cerebellar Ataxia.

TitleSequelae of Lassa Fever: Postviral Cerebellar Ataxia.
Publication TypeJournal Article
Year of Publication2019
AuthorsEzeomah C, Adoga A, Ihekweazu C, Paessler S, Cisneros I, Tomori O, Walker D
JournalOpen Forum Infect Dis
Volume6
Issue12
Paginationofz512
Date Published2019 Dec
ISSN2328-8957
Abstract

Lassa fever is a zoonotic disease endemic in some West African countries. It is exported to countries in America, Asia, and Europe. Antivirals against Lassa fever are important to provide a cure in patients with the disease and provide protection against it. In addition, due to the potential utilization of Lassa virus as a bioterrorism agent, vaccines against the disease can be utilized as a counterterrorism measure. Developing antiviral compounds and vaccines against the disease requires understanding of the pathogenesis of Lassa fever and its disease course, including the signs, symptoms, complications, and sequelae. An important sequela of Lassa fever is ataxia. A few cases of postviral ataxia following Lassa fever have been described in the literature. This review focuses on highlighting these cases, the gaps in scientific knowledge where further research is needed, and possible ways of diagnosing postviral ataxia after Lassa fever in resource-limited settings.

DOI10.1093/ofid/ofz512
Alternate JournalOpen Forum Infect Dis
PubMed ID31879673
PubMed Central IDPMC6923636
Division: 
Biostatistics
Category: 
Student Publication